范可尼贫血的无照射、T细胞充足单倍体移植:权衡获益
范可尼贫血(FA)的最佳单倍体造血细胞移植方案尚未确立,因疾病罕见、对DNA损伤剂敏感性增高及重度移植物抗宿主病(GVHD)风险高。Xu等报告FA患者在不接受照射的情况下可实现良好植入和短期生存,但其回顾性队列重度GVHD发生率高。本文评论探讨T细胞充足单倍体移植的结局,并思考若去除全身照射会限制移植后环磷酰胺的安全给药,这是否为FA患者的最佳方法。
要点
- Xu等报告FA患者无照射预处理可实现良好植入和短期生存,但重度GVHD发生率高。
- FA患者对DNA损伤剂敏感性增高且重度GVHD风险高,最佳单倍体移植方案未确立。
- 评论探讨去除全身照射是否因限制移植后环磷酰胺安全给药而并非FA患者最佳方法。
核心结论
- Xu等提示FA患者无照射可实现良好植入和短期生存,但其回顾性队列重度GVHD发生率高。
- 评论探讨在T细胞充足单倍体移植中,若去除全身照射限制移植后环磷酰胺的安全给药,这是否为FA患者的最佳方法。
研究设计与样本
- 本文为评论性文章,针对Xu等发表于Br J Haematol 2022;199:401-410的回顾性分析进行评论。
主要发现
- Xu等报告FA患者无照射预处理可实现良好植入和短期生存。
- Xu等的回顾性队列重度GVHD发生率高。
局限性
- Xu等的队列为回顾性队列,重度GVHD发生率高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The optimal haploidentical haematopoietic cell transplant approach for Fanconi anaemia (FA) patients is not well established, given the rarity of the disease, the increased sensitivity to DNA-damaging agents and the high risk of severe graft-versus-host disease (GVHD). The report by Xu et al. suggests that excellent engraftment and short-term survival can be achieved in FA patients without irradiation, but their retrospective cohort was plagued by a high rate of severe GVHD. Our commentary explores the outcomes in T-cell replete haploidentical haematopoietic cell transplant and ponders whether elimination of total body irradiation in FA patients is the best method if it limits the ability to safely administer post-transplant cyclophosphamide. Commentary on: Xu et al. Unmanipulated haploidentical haematopoietic cell transplantation with radiation-free conditioning in Fanconi anaemia: A retrospective analysis from the Chinese Blood and Marrow Transplantation Registry Group. Br J Haematol. 2022;199:401-410.
引用
- Connelly JA, Savani BN. Irradiation-free, T-cell replete haploidentical transplant for Fanconi anaemia, weighing the benefits. Br J Haematol. 2022. PMID: 36121005. doi:10.1111/bjh.18446
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。